Literature DB >> 6189515

Binding of hormones and neuropeptides by calmodulin.

D A Malencik, S R Anderson.   

Abstract

Calmodulin exhibits high-affinity, calcium-dependent binding of 1 mol/mol of the vasoactive intestinal peptide (VIP), secretin, and either the 42- or 43-residue gastric inhibitory peptide (GIP) with dissociation constants of 0.05-0.14 microM. The affinity of VIP for calmodulin approaches its affinity for the cell-surface VIP receptors. These peptides compete with both smooth muscle myosin light chain kinase and glucagon in calmodulin binding. Calculation of amino acid frequencies for eight calmodulin binding peptides (VIP, GIP, secretin, ACTH, beta-endorphin, substance P, glucagon, and dynorphin [Malencik, D. A., & Anderson, S. R. (1982) Biochemistry 21, 3480]) shows a below-average incidence of glutamyl residues, above-average incidence of glutaminyl residues, and average incidence of both aspartyl and asparaginyl residues. Predictions of structure from sequence suggest that the bound peptides contain strongly basic turns and coils in close association with regions having above-average beta-sheet potential. The temperature dependence of glucagon binding by calmodulin shows that the association is enthalpy driven.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6189515     DOI: 10.1021/bi00277a040

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

1.  Systematic control of protein interaction using a modular ER/K α-helix linker.

Authors:  Sivaraj Sivaramakrishnan; James A Spudich
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-28       Impact factor: 11.205

2.  Protection by chlorpromazine, albumin and bivalent cations against haemolysis induced by melittin, [Ala-14]melittin and whole bee venom.

Authors:  S V Rudenko; E E Nipot
Journal:  Biochem J       Date:  1996-08-01       Impact factor: 3.857

3.  Protein-peptide affinity determination using an h/d exchange dilution strategy: application to antigen-antibody interactions.

Authors:  Tingting Tu; Mihaela Drăguşanu; Brînduşa-Alina Petre; Don L Rempel; Michael Przybylski; Michael L Gross
Journal:  J Am Soc Mass Spectrom       Date:  2010-03-28       Impact factor: 3.109

4.  Affinity purification of seminalplasmin and characterization of its interaction with calmodulin.

Authors:  M Comte; A Malnoë; J A Cox
Journal:  Biochem J       Date:  1986-12-01       Impact factor: 3.857

5.  Differential regulation of bovine brain calmodulin-dependent cyclic nucleotide phosphodiesterase isoenzymes by cyclic AMP-dependent protein kinase and calmodulin-dependent phosphatase.

Authors:  R K Sharma; J H Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

Review 6.  Biological significance of phosphorylation and myristoylation in the regulation of cardiac muscle proteins.

Authors:  R V Raju; R Kakkar; J M Radhi; R K Sharma
Journal:  Mol Cell Biochem       Date:  1997-11       Impact factor: 3.396

7.  Endothelium-dependent and endothelium-independent vasodilatation of the hepatic artery of the rabbit.

Authors:  A L Brizzolara; G Burnstock
Journal:  Br J Pharmacol       Date:  1991-05       Impact factor: 8.739

8.  In vitro phosphorylation of bovine cardiac muscle high molecular weight calmodulin binding protein by cyclic AMP-dependent protein kinase and dephosphorylation by calmodulin-dependent phosphatase.

Authors:  R Kakkar; S Taketa; R V Raju; S Proudlove; P Colquhoun; K Grymaloski; R K Sharma
Journal:  Mol Cell Biochem       Date:  1997-12       Impact factor: 3.396

9.  Identification of the calmodulin-binding domain of skeletal muscle myosin light chain kinase.

Authors:  D K Blumenthal; K Takio; A M Edelman; H Charbonneau; K Titani; K A Walsh; E G Krebs
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

10.  Inhibition of calmodulin-dependent myosin light-chain kinase by growth-hormone-releasing factor and vasoactive intestinal peptide.

Authors:  H Shiraga; D Stallwood; M Ebadi; R Pfeiffer; D Landers; S Paul
Journal:  Biochem J       Date:  1994-06-15       Impact factor: 3.857

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.